NSE
Krishna Institute of Medical Sciences LimitedKIMS
Krishna Institute of Medical Sciences Limited is an NSE-listed company (KIMS).
AI-generated overview β verify before relying on it.
Net institutional flow
+βΉ0 Cr
Institutional buyers
1 in / 1 out
High-impact filings
1 Β· tilt Neutral
Next corporate action
β
Competitive landscape β the read
vs mapped peers| # | Company | Inst. flow βΉCr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ACUTAAS | +βΉ98.2 Cr | 1 | β | β | +4 | 6 |
| 2 | AAVAS | +βΉ79.7 Cr | 5 | β | β | β | β |
| 3 | KIMSThis | +βΉ0 Cr | 10 | 1 | β | β | β |
| 4 | AADHARHFC | β | β | β | β | β | β |
| 5 | AARTIIND | +βΉ0 Cr | 4 | β | β | β | β |
| 6 | ACE | +βΉ0 Cr | 2 | β | β | β | β |
| 7 | ACMESOLAR | ββΉ80.9 Cr | 1 | β | β | +3 | 6 |
| 8 | ABLBL | ββΉ314.4 Cr | 29 | β | β | β | β |
| 9 | ABFRL | ββΉ730.3 Cr | 13 | β | +1 | β | β |
Ranked by net institutional flow (buys β sells, βΉCr). Filing momentum = bullish β bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline β KIMS day by day
- 2026-06-16FilingAudited Standalone and Consolidated Financial Statements for the Financial Year ended 31st March 2026.Results
- 2026-06-13FilingKrishna Institute of Medical Sciences Limited has informed the Exchange regarding Outcome of Board Meeting helBoard Meeting
- 2026-06-11FilingDr. Bhaskara Rao Bollineni has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) read withShareholding Disclosure
- 2025-09-05BlockSELL Β· βΉ18.1 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-09-05BlockBUY Β· βΉ18.1 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-09-02BlockSELL Β· βΉ36.5 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-09-02BlockBUY Β· βΉ36.5 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-08-29BlockSELL Β· βΉ18.6 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-08-29BlockBUY Β· βΉ18.6 CrGOLDMAN SACHS BANK EUROPE SE - ODI
Merged from deals, filings, corporate actions and news β newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 7
- 4
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) read with Regulation 31(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF β
6 deals Β· 2025-08-29 β 2025-09-05
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2025-09-05 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | βΉ18.1 Cr |
| 2025-09-05 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | βΉ18.1 Cr |
| 2025-09-02 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | βΉ36.5 Cr |
| 2025-09-02 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | βΉ36.5 Cr |
| 2025-08-29 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | βΉ18.6 Cr |
| 2025-08-29 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | βΉ18.6 Cr |
6 deals in the selected window β corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
News & chatter on KIMS
RSS News
0No recent news.
Google News RSS β links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.